Delivery Order SPE2DB24D2011-SPE2DB25FBPUX
Award Date
1/15/25
Potential Completion Date
1/16/25
Potential Value
$2.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,377.45, is for the supply of OPZELURA 1.5% Cream, a specialty pharmaceutical product. The contract is a firm fixed-price arrangement and has an ultimate completion date of March 7, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,276.75, is for the delivery of OPZELURA 1.5% Cream (60 GM). This appears to be a Firm Fixed Price Delivery Order contract, with an ultimate completion date of November 1, 2024. The contract is not designated with a set-aside requirement, indicating open competition....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,367.93, is for the supply of OPZELURA 1.5% CREAM 60GM, a pharmaceutical product. The contract has a period of performance through March 10, 2025 and is a firm fixed-price arrangement. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,330.79, is for the supply of OPZELURA 1.5% Cream, a pharmaceutical product. The contract has a performance period through May 12, 2023 and is a Firm Fixed Price type. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support...
This federal contract award, valued at $4,119.17, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award covers the delivery of OPZELURA 1.5% cream, a pharmaceutical product, with a final completion date of January 7, 2025. The contract is a delivery order with a firm fixed price pricing type, and it does not have a set-aside designation, indicating open competition. Amerisourcebergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $18,234.21, is for the delivery of OPZELURA 1.5% Cream (60 gm) to support military healthcare programs. The contract is a firm fixed-price arrangement with an ultimate completion date of October 26, 2023. It is not designated as a set-aside contract. AmerisourceBergen...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,756.15 delivery order is for OPZELURA 1.5% CREAM 60GM, a medical supply product. The contract is a firm fixed-price delivery order with an ultimate completion date of January 24, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,039.11 firm-fixed-price delivery order is for the supply of OPZELURA 1.5% cream, a pharmaceutical product, to support the DLA's medical requirements. The contract has an ultimate completion date of July 11, 2024 and was awarded on July 10, 2024. This award is associated with Amerisourcebergen's $999,999,999...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of OPZELURA 1.5% cream with a ceiling value of $1,250.23. The contract has an ultimate completion date of March 21, 2024 and is a Firm Fixed Price type. This contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,886.13 firm fixed-price delivery order contract is for the supply of OPZELURA 1.5% Cream, a pharmaceutical product. The contract has an ultimate completion date of February 7, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...